[{"Assets_0_Q3_USD":7514553000.0,"EarningsPerShareDiluted_3_Q3_USD":2.28,"EarningsPerShareDiluted_1_Q3_USD":0.22,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":256289000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":256946000.0,"EarningsPerShareBasic_3_Q3_USD":2.32,"EarningsPerShareBasic_1_Q3_USD":0.22,"RevenuesConverted_1_Q3_USD":949828000.0,"StockholdersEquityConverted_0_Q3_USD":5253394000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":260473000.0,"NetIncomeLossConverted_3_Q3_USD":593576000.0,"NetIncomeLossConverted_1_Q3_USD":57518000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":1123322000.0,"CommonStockSharesOutstanding_0_Q3_shares":257265000.0,"CommonStockSharesConverted_0_Q3_shares":257265000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":260182000.0,"RevenuesConverted_3_Q3_USD":2749556000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20191031"}]